Year: 2021

Rye a better choice than wheat for weight loss

Rye a better choice than wheat for weight loss

Eating whole grain rye products instead of refined wheat alternatives can offer worthwhile health benefits. Researchers at Chalmers University of Technology, Sweden, recently published a study showing that people who ate high-fiber products made from whole grain rye lost more body fat and overall weight than those who ate corresponding products made from refined wheat….

Vaccine Mandate Dissenters Smeared

Vaccine Mandate Dissenters Smeared

October 4, 2021, Southwest Airlines sent an announcement to its employees informing them that “because Southwest Airlines is a federal contractor,” the airline is “required to comply with the government federal contractor mandate for employees to be fully vaccinated against COVID-19.”1 The following weekend, October 9 and 10, 2021, the airline was forced to cancel…

Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery.

Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery.

PMID:  Food Chem Toxicol. 2021 Sep 25 ;157:112576. Epub 2021 Sep 25. PMID: 34571052 Abstract Title:  Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery. Abstract:  Cancer is the second leading cause of death worldwide. Majority of recent research efforts in the field aim to address why cancer resistance to therapy…

What parents need to know about a rise in RSV

What parents need to know about a rise in RSV

After a year of COVID-19 precautions that saw virtually no cases of this common childhood illness, respiratory syncytial virus (RSV) is back with a vengeance, and health care professionals are concerned. “The symptoms are virtually synonymous with the common cold – runny nose, congestion, maybe a little cough – but RSV is associated with a…

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

PMID:  EBioMedicine. 2021 Sep ;71:103561. Epub 2021 Aug 27. PMID: 34455390 Abstract Title:  Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. Abstract:  BACKGROUND: Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting risk of reinfection and durability of vaccine protection.METHODS: This is a prospective, monocentric, longitudinal,…

Close
Menu